Western diet-induced fear memory impairment is attenuated by 6-shogaol in C57BL/6N mice

2020 ◽  
Vol 380 ◽  
pp. 112419
Author(s):  
Michael O. Gabriel ◽  
Maria Nikou ◽  
Oluwole B. Akinola ◽  
Daniela D. Pollak ◽  
Spyridon Sideromenos
2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Xiaoxuan Yang ◽  
Guohui Li ◽  
Qingsheng Xue ◽  
Yan Luo ◽  
Sensen Wang ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (19) ◽  
pp. 5977
Author(s):  
Marta Kruk-Slomka ◽  
Grazyna Biala

Schizophrenia is a chronic mental disorder that disturbs feelings and behavior. The symptoms of schizophrenia fall into three categories: positive, negative, and cognitive. Cognitive symptoms are characterized by memory loss or attentional deficits, and are especially difficult to treat. Thus, there is intense research into the development of new treatments for schizophrenia-related responses. One of the possible strategies is connected with cannabidiol (CBD), a cannabinoid compound. This research focuses on the role of CBD in different stages of memory (acquisition, consolidation, retrieval) connected with fear conditioning in the passive avoidance (PA) learning task in mice, as well as in the memory impairment typical of cognitive symptoms of schizophrenia. Memory impairment was provoked by an acute injection of the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 (animal model of schizophrenia). Our results revealed that an acute injection of CBD (30 mg/kg; intraperitoneally (i.p.) improved all phases of long-term fear memory in the PA test in mice. Moreover, the acute injection of non-effective doses of CBD (1 or 5 mg/kg; i.p.) attenuated the memory impairment provoked by MK-801 (0.6 mg/kg; i.p.) in the consolidation and retrieval stages of fear memory, but not in the acquisition of memory. The present findings confirm that CBD has a positive influence on memory and learning processes in mice, and reveals that this cannabinoid compound is able to attenuate memory impairment connected with hypofunction of glutamate transmission in a murine model of schizophrenia.


2022 ◽  
Author(s):  
Masanori Nomoto ◽  
Emi Murayama ◽  
Shuntaro Ohno ◽  
Reiko Okubo-Suzuki ◽  
Shin-ichi Muramatsu ◽  
...  

In entorhinal-hippocampal networks, the trisynaptic pathway, including the CA3 recurrent circuit, processes episodes of context and space. Recurrent connectivity can generate reverberatory activity, an intrinsic activity pattern of neurons that occurs after sensory inputs have ceased. However, the role of reverberatory activity in memory encoding remains incompletely understood. Here we demonstrate that in mice, synchrony between conditioned stimulus (CS) and unconditioned stimulus (US)-responsible cells occurs during the reverberatory phase, lasting for approximately 15 s, but not during CS and US inputs, in the CA1 and the reverberation is crucial for the linking of CS and US in the encoding of delay-type cued-fear memory. Retrieval-responsive cells developed primarily during the reverberatory phase. Mutant mice lacking N-methyl-D-aspartate receptors (NRs) in CA3 showed a cued-fear memory impairment and a decrease in synchronized reverberatory activities between CS- and US-responsive CA1 cells. Optogenetic CA3 silencing at the reverberatory phase during learning impaired cued-fear memory. Our findings suggest that reverberation recruits future retrieval-responsive cells via synchrony between CS- and US-responsive cells. The hippocampus uses reverberatory activity to link CS and US inputs, and avoid crosstalk during sensory inputs.


2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Kanathip Singsai ◽  
Natthanicha Ladpala ◽  
Natthan Dangja ◽  
Thanyaret Boonchuen ◽  
Niracha Jaikhamfu ◽  
...  

Streblus asper (SA) is well known as a folk medicinal plant in Asian countries. The effect of SA extract on preventing memory impairment in zebrafish induced by scopolamine was investigated. Male zebrafish, Danio rerio, were divided into 6 groups including the control, scopolamine 200 μM (SCO), scopolamine plus rivastigmine 1.5 mg/kg (RV + SCO), and scopolamine plus SA extract at doses of 200, 400, and 800 mg/kg (SA200 + SCO, S400 + SCO, and SA800 + SCO), respectively. Spatial memory was evaluated by the colour-biased appetite conditioning T-maze test, while fear memory was measured by the inhibitory avoidance test. In the spatial memory test, results showed that the RV + SCO group had the best time spent ratio in the T-maze, followed by SA800 + SCO, SA400 + SCO, SA200 + SCO, control, and SCO group, respectively, but with no statistical significance. For the fear memory test, zebrafish that received SA at doses of 200, 400, and 800 mg/kg had significantly increased latency time as 21.75 ± 4.59, 23.75 ± 13.01, and 18.20 ± 18.84 min, respectively, when compared to the SCO group (9.80 ± 10.45 min). These results suggested that SA extract attenuated memory impairment in an inhibitory avoidance test related to fear memory. Our findings can be useful for further research to develop SA extract as a health product to ameliorate the symptoms of Alzheimer’s disease.


2013 ◽  
Vol 58 ◽  
pp. 156-168 ◽  
Author(s):  
Elise Morice ◽  
Séverine Farley ◽  
Roseline Poirier ◽  
Glenn Dallerac ◽  
Carine Chagneau ◽  
...  

1989 ◽  
Vol 34 (1) ◽  
pp. 69-70
Author(s):  
Marion Perlmutter
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document